Heart failure with preserved ejection fraction (HFpEF) is a growing epidemic owing to an
increasingly obese and aging patient population. Making the diagnosis of HFpEF is often …

There are few proven therapies for heart failure with preserved ejection fraction (HFpEF).
The lack of therapies, along with increased recognition of the disorder and its underlying …

Over the last several decades, clinicians and clinical scientists have had growing interest in
heart failure (HF) diagnosis and treatment. While HF with reduced ejection fraction (EF) is a …

Heart failure with preserved ejection fraction (HFpEF) is a common clinical syndrome
associated with high rates of morbidity and mortality. Due to the lack of evidence-based …

Heart failure with preserved ejection fraction (HFpEF) is characterized by a notable
heterogeneity in both phenotypic and pathophysiological features, with a growing incidence …

Heart failure (HF) with preserved ejection fraction (HFpEF) is a common condition in clinical
practice, affecting more than half of patients with HF. HFpEF is associated with morbidity and …

There is a lack of consensus on how we define heart failure with preserved ejection fraction
(HFpEF), with wide variation in diagnostic criteria across society guidelines. This lack of …

Heart failure with preserved ejection fraction (HFpEF) is a major global public health
problem. Diagnosis of HFpEF is still challenging and built based on the comprehensive …

Heart failure (HF) with preserved ejection fraction (HFpEF) accounts for nearly half of the
cases of HF and its incidence might be increasing with the aging society. Patients with …

Unlike heart failure with reduced ejection fraction (HFrEF), the diagnosis of heart failure with
preserved ejection fraction (HFpEF) remains challenging and controversial. Apart from …